LabConnect Competitors and Similar CompaniesClear all
Esoterix's competitors and similar companies include Quark Pharmaceuticals, Avacta Group and Kura Oncology.
 Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  Avacta Group Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics |  Kura Oncology Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. | ||
Founding Date | Founding Date 1995 | Founding Date 1994 | Founding Date 2003 | Founding Date 2007 |
Type | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Austin, US HQ Calabasas, US Englewood, US | Locations Newark, US HQ | Locations Wetherby, GB HQ London, GB Whittlesford, GB | Locations San Diego, US HQ Boston, US San Diego, US San Diego, US |
Employees | Employees 1131% increase | Employees 781% decrease | Employees 154 | Employees 5712% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 264.5 m | Valuation ($) 1.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £6.3m (FY, 2025) | Revenue (est.) $67.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Quark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View companyAvacta Group
HQ
Wetherby, GB
Employees
154
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
View companyKura Oncology
HQ
San Diego, US
Employees
57↑ 12% increase
Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
View company